Relmada Therapeutics (RLMD) Times Interest Earned (2012 - 2026)
Relmada Therapeutics' (RLMD) quarterly Times Interest Earned came in at -$0.51 in Q1 2026, up 99.87% year-on-year from -$0.26 in Q1 2025, and up 99.94% on a QoQ basis from -$807.99 in Q4 2025.
Relmada Therapeutics (RLMD) Times Interest Earned (2012 - 2026) Analysis & Trends
Relmada Therapeutics (RLMD) has 15 years of Times Interest Earned data on file, last reported at -$0.51 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 99.87% year-over-year to -$0.51 in Q1 2026; TTM through Mar 2026 was -$1.59, a 99.73% increase from a year earlier, with the FY2025 full-year figure at -$8.55, up 98.62% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.51, up from -$807.99 in the prior quarter.
- Over the last five years, Times Interest Earned for RLMD reached as high as -$0.51 in Q1 2026 and fell as low as -$1209.5 in Q4 2023.
- Historically, Times Interest Earned has averaged -$433.79 across 5 years, with a median of -$490.34 in 2023.
- Across the five-year window, Times Interest Earned tumbled 25956.08% in 2022 and jumped 99.87% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$92.59 in 2022, then sank by 1206.31% to -$1209.5 in 2023, then jumped by 43.67% to -$681.32 in 2024, then decreased by 18.59% to -$807.99 in 2025, then jumped by 99.94% to -$0.51 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.51 in Q1 2026, -$807.99 in Q4 2025, and -$381.94 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - | -0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.51 |
| Dec 31, 2025 | -807.99 |
| Mar 31, 2025 | -381.94 |
| Dec 31, 2024 | -681.32 |
| Sep 30, 2024 | -38.35 |
| Jun 30, 2024 | -53.45 |
| Mar 31, 2024 | -1.52 |
| Dec 31, 2023 | -1,209.51 |
| Sep 30, 2023 | -598.75 |
| Jun 30, 2023 | -642.64 |
| Mar 31, 2023 | -696.87 |
| Dec 31, 2022 | -92.59 |
| Dec 31, 2021 | -0.36 |
| Mar 31, 2021 | -555.68 |
| Sep 30, 2020 | -11,761.52 |
| Jun 30, 2020 | 8,731.83 |
| Mar 31, 2020 | -1,237.83 |
| Dec 31, 2019 | -806.12 |
| Sep 30, 2019 | -1,515.32 |
| Jun 30, 2019 | -1,545.59 |